Anthrax said:
I thought you recommended 9 mg of melatonin (see your original post)
As for 5-HTP there are studies stating that 100mg befoe bed on an empty stomach is all that you need
GABA : I've read studies about GABA not crossing the brain barrier making it completely useless
Kava : I tried and it didn't do jack shit to me
anyway I'm confident your stack "works" but it's more than $2-3 a pill....
The 9 was a typo, it was supposed to be a bracket.
I guess what works for different people is individual.
If you must economise, take the GABBA/ taurine/ pyroxidine combination as their effects are synergistic. Theanine is also excellent -it is the ingredient in green tea that makes you feel calm (it stimulates alpha waves in the brain), inspite of the caffeine content. As such it is excellent for combatting the effects of stimulants. Melatonin really is the most effective supplement tho.
Here is some more info about 5HTP:
NOTE DOSEAGE RECCOMENDATIONS-
Dosage Should you decide to use 5-HTP, the typical dose is 300-900mg per day (usually in 2-3 doses throughout the day).
Hydroxy-tryptophan (5-HTP)
Description 5-HTP is a derivative of the amino acid tryptophan (a hydroxyl group added to the 5-position). In the body, tryptophan is converted into 5-HTP, which then can be converted into serotonin (a potent neurotransmitter in the brain). Although 5-HTP is not found at any significant level in a normal diet, tryptophan is found in a wide variety of protein foods. The 5-HTP used in dietary supplements is derived from the seeds of and African plant (Griffonia simplicifolia).
Claims Relieves mild to moderate depression
Relieves insomnia and promotes restful sleep
Promotes weight loss by suppressing appetite
Reduces overall sensation of pain (migraine headaches, fibromyalgia, general muscle pain)
Theory 5-HTP is typically used to treat mild depression based on the theory that as a precursor to serotonin, supplements of 5-HTP can increase serotonin levels and influence mood, sleep patterns and pain control. The amino acid, tryptophan, can also be broken down in the body to yield ribose and/or NAD – both of which have been associated with increased energy levels. While these are certainly logical theories, the scientific evidence supporting them remains moderate at best.
Scientific Support As indicated above, the overall scientific evidence for the effectiveness of 5-HTP is not very strong. In a few small studies, however, 5-HTP has been shown to be as effective as prescription antidepressant medications – and with fewer side effects – but there are just as many controlled clinical trials which have shown no effect of 5-HTP in alleviating mood disturbances. In other studies, doses of 5-HTP in the range of 300-900mg/day have resulted in benefits in reducing pain (migraines and fibromyalgia), reducing appetite and promoting sleep (possibly by increasing blood levels of melatonin). In some studies, it appears that there are “responders” – those individuals who experience an elevation in 5-HTP levels in the blood, as well as “non-responders” – who see no such increase
Several studies have investigated 5-HTP supplementation in conjunction with SSRI medications (selective serotonin reuptake inhibitors such as fenfluramine and fluoxetine – Prozac). In this combination, 5-HTP could be expected to help increase serotonin synthesis, while the SSRIs would keep those levels elevated – but this hypothesis has not been shown to be particularly effective. In at least one study, 5-HTP actually appeared to cause an increase in depressive symptoms in healthy subjects – exactly the opposite effect that users of the supplement are looking for.
Safety The most significant safety concern related to 5-HTP supplements is the remote possibility for contamination with a compound linked to a disorder known as eosinophilic myalgia syndrome (EMS). Several years ago (1989), an outbreak of EMS (which results in muscle pain and weakness, vomiting, headache and in rare cases, death) was linked to contaminated tryptophan supplements (not to the tryptophan per se, but to a contaminant in the tryptophan supplements). As a result, the FDA banned the sale of all tryptophan supplements (a move that has been widely criticized by people on both sides of the supplement debate). In some rare cases, 5-HTP supplements have been linked (anecdotally) to gastrointestinal distress, muscle pain, lethargy and headaches
The banned tryptophan supplements were manufactured from a bacterial source (fermentation process), while 5-HTP is extracted from the seeds of a plant – so it is less likely (though not impossible) that the contaminant associated with EMS is present in 5-HTP supplements (commonly known as “peak X”). However, the FDA issued a “talk paper” in 1998 which seemed to confirm the presence of “peak X” at low levels in several commercially available brands of 5-HTP – raising the possibility that EMS could strike those taking 5-HTP supplements (see FDA statement below). Although the FDA has not taken any action, such as removing 5-HTP from the market or issuing any precautions against using 5-HTP, anybody considering using this supplement should use a brand from a reputable company (such as the Serotain brand of 5-HTP from Triarco). Some supplement manufacturers and raw material suppliers conduct quality control tests to confirm the absence of “peak X” in their 5-HTP supplements. If you decide to try 5-HTP, we suggest contacting the manufacturer of your supplement for confirmation that their products have passed this type of analysis.
In addition to the above safety considerations, 5-HTP supplements are not recommended for children or for women who are pregnant or lactating. Those individuals currently taking prescription antidepressants, weight control medications or herbal remedies for depression (such as St. John’s wort) should not combine these treatments with 5-HTP supplements (except on the advice and guidance of a nutritionally-oriented physician).
=======================================
**Note: the following text comes from the Food and Drug Administration. This report is based on an FDA-supported analysis of 5-HTP supplements and confirms findings reported in a short letter that Mayo Clinic researchers published in the journal Nature Medicine. The original letter has been widely criticized for having “political overtones” and for being openly “anti-supplement” – which is to say that the results should probably speak for themselves (that the “peak X” contaminant was indeed found at low levels), but that the interpretation of these findings (that 5-HTP supplements pose a health threat) is open to debate. Of particular interest is the fact that, worldwide, only 10 cases of EMS have been associated with 5-HTP-containing products (not linked directly to purified 5-HTP). When considered in terms of the millions of people currently using 5-HTP supplements on a regular basis, the “threat” of 5-HTP contamination as a public health menace is probably not large – but more research certainly needs to be done to confirm safety.
From the FDA website – view at
http://vm.cfsan.fda.gov/~lrd/tp5htp.html
August 31, 1998
IMPURITIES CONFIRMED IN DIETARY SUPPLEMENT 5-HYDROXY-L-TRYPTOPHAN
FDA scientists have confirmed the presence of impurities in some 5-hydroxy-L-tryptophan (5HTP) products currently marketed and widely promoted as dietary supplements. These products are being used as aids for insomnia, depression, obesity, and in children with attention deficit disorder. FDA's analytical results are consistent with those obtained and published by researchers from the Mayo Clinic.
One of these impurities is known as "peak X." Although the significance of finding "peak X" and other impurities in dietary supplements containing 5-HTP is unknown, past experiences with these products suggests vigilance is warranted. "Peak X" was identified in one case of the illness eosinophilia-myalgia syndrome (EMS) associated with 5HTP in 1991. Impurities similar to "peak X" were also found in L-tryptophan that was associated with a 1989 epidemic of EMS. 5HTP and L-tryptophan are related in that 5HTP is synthesized from L-tryptophan in the body. The exact cause of the 1989 epidemic and of the case of EMS associated with 5HTP remain unclear.
EMS is a serious systemic illness characterized by elevations of certain white blood cells and severe muscle pain. The Centers for Disease Control and Prevention (CDC) has identified more than 1,500 cases of EMS, including at least 38 deaths associated with the use of L-tryptophan. The medical literature reports approximately 10 previous cases of EMS worldwide associated with use of products containing 5HTP.
Research has not resolved whether these EMS were caused by L-tryptophan or 5HTP, one or more impurities, or other factors. At this time, FDA is unaware of any recent illnesses associated with the 5HTP products being sold as dietary supplements. The widespread promotion and use of these products, however, began only recently.
Value Because commonly prescribed antidepressant medications are ineffective in about 30% of depressed patients, and because depression and anxiety disorders are associated with brains imbalances in serotonin, 5-HTP supplements would seem to be a logical approach to boosting serotonin levels and mood. Unfortunately, the scientific evidence for effectiveness is not strong – even though a few small studies have shown 5-HTP supplements to be beneficial in several serotonin-related conditions, many other studies have shown no benefits.
Dosage Should you decide to use 5-HTP, the typical dose is 300-900mg per day (usually in 2-3 doses throughout the day).
PART 2 PART 2 PART 2 PART 2 PART 2 PART 2 PART 2 PART 2 PART 2
Here are some studies, those which mention doses, see 5-HTP used at higher daily doses that I have prescribed (300 at bed time being optimum for the required purpose)
Altern Med Rev 1998 Aug;3(4):271-80
5-Hydroxytryptophan: a clinically-effective serotonin precursor.
Birdsall TC.
[email protected]
5-Hydroxytryptophan (5-HTP) is the intermediate metabolite of the essential amino acid L-tryptophan (LT) in the biosynthesis of serotonin. Intestinal absorption of 5-HTP does not require the presence of a transport molecule, and is not affected by the presence of other amino acids; therefore it may be taken with meals without reducing its effectiveness. Unlike LT, 5-HTP cannot be shunted into niacin or protein production. Therapeutic use of 5-HTP bypasses the conversion of LT into 5-HTP by the enzyme tryptophan hydroxylase, which is the rate-limiting step in the synthesis of serotonin. 5-HTP is well absorbed from an oral dose, with about 70 percent ending up in the bloodstream. It easily crosses the blood-brain barrier and effectively increases central nervous system (CNS) synthesis of serotonin. In the CNS, serotonin levels have been implicated in the regulation of sleep, depression, anxiety, aggression, appetite, temperature, sexual behaviour, and pain sensation. Therapeutic administration of 5-HTP has been shown to be effective in treating a wide variety of conditions, including depression, fibromyalgia, binge eating associated with obesity, chronic headaches, and insomnia.
Am J Clin Nutr 1992 Nov;56(5):863-7
Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophan.
Cangiano C, Ceci F, Cascino A, Del Ben M, Laviano A, Muscaritoli M, Antonucci F, Rossi-Fanelli F.
3rd Department of Internal Medicine, University of Rome, La Sapienza, Italy.
Previous observations have shown that oral administration of 5-hydroxytryptophan (5-HTP) without dietary prescriptions causes anorexia, decreased food intake, and weight loss in obese subjects. To confirm these data over a longer period of observation and to verify whether adherence to dietary restriction could be improved by 5-HTP, 20 obese patients were randomly assigned to receive either 5-HTP (900 mg/d) or a placebo. The study was double-blinded and was for two consecutive 6-wk periods. No diet was prescribed during the first period, a 5040-kJ/d diet was recommended for the second. Significant weight loss was observed in 5-HTP-treated patients during both periods. A reduction in carbohydrate intake and a consistent presence of early satiety were also found. These findings together with the good tolerance observed suggest that 5-HTP may be safely used to treat obesity.
Int J Obes Relat Metab Disord 1998 Jul;22(7):648-54
Effects of oral 5-hydroxy-tryptophan on energy intake and macronutrient selection in non-insulin dependent diabetic patients.
Cangiano C, Laviano A, Del Ben M, Preziosa I, Angelico F, Cascino A, Rossi-Fanelli F.
Department of Clinical Medicine, University of Rome La Sapienza, Italy.
OBJECTIVE: In obese patients, brain serotonergic stimulation via orally administered 5-hydroxy-tryptophan (5-HTP), the precursor of serotonin, causes decreased carbohydrate intake and weight loss. Since diabetes mellitus is associated with depressed brain serotonin, hyperphagia and carbohydrate craving, we hypothesized that in diabetic patients, orally administered 5-HTP stimulates brain serotonergic activity and thus normalizes eating behaviour. To test this hypothesis, we investigated whether in diabetic patients: 1) predicted brain serotonin concentrations are depressed as a result of decreased availability of the precursor, tryptophan; and 2) oral 5-HTP is effective in reducing energy and carbohydrate intake. SUBJECTS AND METHODS: 25 overweight non-insulin dependent diabetic outpatients were enrolled in a double-blind, placebo-controlled study, and randomized to receive either 5-HTP (750 mg/d) or placebo for two consecutive weeks, during which no dietary restriction was prescribed. Energy intake and eating behaviour, as expressed by macronutrient selection, were evaluated using a daily diet diary. Plasma amino acid concentrations and body weight, as well as serum glucose, insulin and glycosylated haemoglobin were assessed. RESULTS: 20 patients (nine from the 5-HTP group and 11 from the Placebo group) completed the study. Brain tryptophan availability in diabetic patients was significantly reduced when compared to a group of healthy controls. Patients receiving 5-HTP significantly decreased their daily energy intake, by reducing carbohydrate and fat intake, and reduced their body weight. CONCLUSIONS: These data confirm the role of the serotonergic system in reducing energy intake, by predominantly inhibiting carbohydrate intake, and suggest that 5-HTP may be safely utilized to improve the compliance to dietary prescriptions in non-insulin dependent diabetes mellitus.
J Int Med Res 1990 May-Jun;18(3):201-9
Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome.
Caruso I, Sarzi Puttini P, Cazzola M, Azzolini V.
Rheumatology Unit, L. Sacco Hospital, Milan, Italy.
A double-blind, placebo-controlled study of the efficacy and tolerability of 5-hydroxytryptophan (5-HTP) was conducted in 50 patients with primary fibromyalgia syndrome. All the clinical parameters studied were significantly improved by treatment with 5-HTP and only mild and transient side-effects were reported. Further controlled studies are required to define properly the value of 5-HTP in patients with primary fibromyalgia syndrome.
Adv Exp Med Biol 1999;467:461-8
Eosinophilia-myalgia syndrome case-associated contaminants in commercially available 5-hydroxytryptophan.
Klarskov K, Johnson KL, Benson LM, Gleich GJ, Naylor S.
Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA.
Recently, 5-hydroxy-L-tryptophan (5-OHTrp) has been promoted as an alternative to banned L-tryptophan as a dietary supplement. It has been claimed to help alleviate obesity, insomnia, depression, and headaches. However, eosinophilia-myalgia syndrome (EMS)-like symptoms have also been associated with ingestion or exposure to 5-OHTrp. HPLC-UV analysis of EMS-implicated 5-OHTrp revealed the presence of peak X, described as case-implicated. We show that peak X is actually a family of contaminants with the same molecular weight (234 Da) and similar HPLC retention times. We also demonstrate that all eight samples of commercially available 5-OHTrp analyzed by HPLC-MS contained three or more contaminants of the peak X family. The significance of these findings is discussed.
J Neural Transm 1989;76(2):109-17
The effects of oral 5-hydroxytryptophan administration on feeding behavior in obese adult female subjects.
Ceci F, Cangiano C, Cairella M, Cascino A, Del Ben M, Muscaritoli M, Sibilia L, Rossi Fanelli F.
Department of Internal Medicine, University of Rome La Sapienza, Italy.
Nineteen obese female subjects with body mass index ranging between 30 and 40 were included in a double-blind crossover study aimed at evaluating the effects of oral 5-hydroxytryptophan administration on feeding behavior, mood state and weight loss. Either 5-hydroxytryptophan (8 mg/kg/day) or placebo was administered for five weeks during which patients were not prescribed any dietary restrictions. Feeding behavior was investigated by means of a questionnaire designed to establish the onset of anorexia and related symptoms. Food intake was evaluated using a three-day diet diary. BDI, SI, STAI-T, and STAI-S were used to assess mood state. The administration of 5-hydroxytryptophan resulted in no changes in mood state but promoted typical anorexia-related symptoms, decreased food intake and weight loss during the period of observation.